Protagenic Therapeutics Inc

Protagenic Therapeutics Inc (PTIX) Price Prediction & Forecast

$0.740

-0.319 (-43.08%)At close

Price Predictions

1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

PTIX stock price ended at $0.74 on Friday, after losing -43.08%

Protagenic Therapeutics Inc (PTIX) last closed at $0.74, losing -43.08%. These facts feed the 1-day and 1-week PTIX price prediction above.

Forecast Drivers

Protagenic Therapeutics Inc (PTIX) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Seasonality analysis for PTIX

Historically the probability of a positive September return for PTIX is 4.88%. May offers the highest probability of a positive month at 53.49%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for PTIX

MonthMin PriceAvg PriceMax PricePotential ROI
Sep 2026$3.30$3.41$3.88+360.37%
Oct 2026$2.79$3.18$3.60+329.86%
Nov 2026$2.94$3.35$3.73+352.99%
Dec 2026$3.62$3.94$4.08+432.48%

In 2026, Protagenic Therapeutics Inc (PTIX) is projected to range from $2.79 to $4.08.

Protagenic Therapeutics Inc 2026 monthly forecast

Sep 2026 PTIX forecast
Potential ROI: 360.37%

In Sep 2026, Protagenic Therapeutics Inc is projected to average $3.41, with a low of $3.30 and high of $3.88.

Oct 2026 PTIX forecast
Potential ROI: 329.86%

In Oct 2026, Protagenic Therapeutics Inc is projected to average $3.18, with a low of $2.79 and high of $3.60.

Nov 2026 PTIX forecast
Potential ROI: 352.99%

In Nov 2026, Protagenic Therapeutics Inc is projected to average $3.35, with a low of $2.94 and high of $3.73.

Dec 2026 PTIX forecast
Potential ROI: 432.48%

In Dec 2026, Protagenic Therapeutics Inc is projected to average $3.94, with a low of $3.62 and high of $4.08.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started